Table 2.
Targeted [3H]-(+)-PTZ concentration (nM) | Measured total radioactivity (DPM) | Measured total [3H]-(+)-PTZ (mmol) | Measured [3H]-(+)-PTZ concentration in assay (nM) |
---|---|---|---|
300 | 2037960 | 2.70E-08 | 270.0 |
100 | 679420 | 9.00E-09 | 90.0 |
30 | 204684 | 2.71E-09 | 27.1 |
10 | 66382 | 8.79E-10 | 8.8 |
3 | 21047 | 2.79E-10 | 2.8 |
1 | 6573 | 8.71E-11 | 0.9 |
0.3 | 2234 | 2.96E-11 | 0.3 |
The first column displays targeted concentrations of [3H]-(+)-pentazocine calculated from the stock vial (34 Ci/mmol or ~29.4 μM). Second column contains radioactivity counts in DPM of the targeted concentration of [3H]-(+)-pentazocine. Third column shows radioactivity values transformed from DPM into millimoles of radioligand (Note: the conversion factor used was 2.22 × 1012 DPM per Ci). The fourth column shows the actual concentrations of [3H]-(+)-pentazocine as calculated from the DPM values obtained.